Center of Excellence: Migraine: News & Perspective
- AAN 2021 Migraineurs Not Taking Advantage of an 'Effective Prophylactic'
- Alert FDA Clears Neuromodulation Device for Acute Migraine Pain
- Nystagmus From Living in the Dark Cured With Light Exposure
- Opioid Overuse in Migraineurs Linked to More Severe Disability
- PFO Closure Reduces Migraine: New Meta-Analysis
- CGRP May Offer Both Migraine Treatment and Prevention
- 'Dramatic Impact' of Mindfulness on Migraine
- HIT-6 Helps Track 'Meaningful Change' in Chronic Migraine
- Migraine Nerve Stimulation Device Now Available Over-the-Counter
- No Migraine 'Rebound' Stopping Clopidogrel After ASD Closure
- Choroid Plexuses May Play a Role in Migraine
- Multiple Traits More Common in Difficult-to-Treat Migraine
- Botulinum Toxin Linked to Antidepressant Effects
- Positive Phase 3 Topline Results for Migraine Prevention Drug
- Visualization Tool Aids Migraine Management
- Migraine Often a Deciding Factor in Pregnancy Planning
- Headache Day 'Threshold' for Chronic Migraine Called Into Question
- NSAID/Triptan Combo Improves Treatment-Resistant Migraine
- Intranasal DHE Promising in Migraine
- CGRPs in Real World: Similar Efficacy, More AEs